Veeva Systems (NYSE:VEEV) Updates FY 2027 Earnings Guidance

Veeva Systems (NYSE:VEEV) issued an update on its FY 2027 earnings guidance on Wednesday. The company provided EPS guidance of 9.210-9.210 for the period, compared to the consensus earnings per share estimate of 8.580. The company issued revenue guidance of $3.7 billion-$3.7 billion, compared to the consensus revenue estimate of $3.6 billion. Veeva Systems also updated its Q3 2027 guidance to 2.330-2.340 EPS.

Analysts Set New Price Targets

Several research firms have recently weighed in on VEEV. The Goldman Sachs Group lowered their price objective on Veeva Systems from $190.00 to $165.00 and set a “sell” rating for the company in a research report on Thursday, June 4th. Weiss Ratings upgraded Veeva Systems from a “hold (c-)” rating to a “hold (c)” rating in a research report on Wednesday, August 12th. BTIG Research reaffirmed a “buy” rating and set a $340.00 target price on shares of Veeva Systems in a research note on Thursday, June 4th. TD Cowen reiterated a “buy” rating on shares of Veeva Systems in a report on Monday. Finally, Wall Street Zen lowered Veeva Systems from a “buy” rating to a “hold” rating in a research note on Monday, August 3rd. Nineteen equities research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $258.08.

Veeva Systems Price Performance

Shares of VEEV stock traded down $2.06 on Wednesday, reaching $244.72. 1,444,137 shares of the company were exchanged, compared to its average volume of 2,454,633. The company has a market cap of $39.75 billion, a price-to-earnings ratio of 43.62, a PEG ratio of 1.07 and a beta of 0.92. The company has a 50-day moving average of $201.60 and a 200-day moving average of $182.61. Veeva Systems has a one year low of $148.05 and a one year high of $310.50.

Veeva Systems (NYSE:VEEV) last issued its earnings results on Wednesday, June 3rd. The technology company reported $2.24 EPS for the quarter, beating analysts’ consensus estimates of $2.14 by $0.10. Veeva Systems had a return on equity of 13.72% and a net margin of 28.37%.The business had revenue of $882.95 million during the quarter, compared to analyst estimates of $857.73 million. During the same period in the previous year, the company posted $1.97 EPS. The firm’s revenue was up 16.3% compared to the same quarter last year. Veeva Systems has set its FY 2027 guidance at 9.050-9.050 EPS and its Q2 2027 guidance at 2.210-2.220 EPS. As a group, sell-side analysts predict that Veeva Systems will post 6.64 EPS for the current year.

Insider Activity at Veeva Systems

In other news, insider Thomas D. Schwenger sold 36,000 shares of the company’s stock in a transaction that occurred on Thursday, August 13th. The stock was sold at an average price of $250.23, for a total transaction of $9,008,280.00. Following the transaction, the insider directly owned 19,449 shares of the company’s stock, valued at $4,866,723.27. This represents a 64.92% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 10.60% of the stock is currently owned by corporate insiders.

Key Veeva Systems News

Here are the key news stories impacting Veeva Systems this week:

• Positive Sentiment: Major customer wins strengthen Vault CRM adoption. Biogen and Regeneron both committed to Veeva Vault CRM globally. The agreements support Veeva’s position in life-sciences commercial software and could contribute to future subscription growth. Veeva Vault CRM Selected by Biogen Veeva Vault CRM Selected by Regeneron
• Positive Sentiment: Truist said the wins reinforce Veeva’s market leadership. The bank characterized Vault CRM as the clear leader in life-sciences CRM ahead of earnings, providing a favorable read-through on competitive positioning and demand. Veeva’s Vault CRM Wins Reinforce Market-Leader Status Ahead of Earnings
• Positive Sentiment: Needham reaffirmed its “Buy” rating. The repeated bullish recommendation adds support to the investment case as investors assess Veeva’s growth prospects and valuation. Needham Reaffirms Buy Rating
• Neutral Sentiment: Piper Sandler initiated coverage. New analyst coverage may increase institutional attention, although the article does not specify the firm’s rating or price target. Veeva Coverage Initiated at Piper Sandler
• Neutral Sentiment: Earnings remain the near-term catalyst. Veeva is scheduled to report second-quarter results after the bell. Its previous quarter exceeded consensus estimates, with revenue up 16.3% year over year, so investors will focus on results, subscription growth, and forward guidance. What to Expect From Veeva Systems’s Q2 Earnings

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the business. J.Safra Asset Management Corp increased its position in shares of Veeva Systems by 2,940.0% during the fourth quarter. J.Safra Asset Management Corp now owns 152 shares of the technology company’s stock worth $34,000 after acquiring an additional 147 shares in the last quarter. Raiffeisen Bank International AG raised its holdings in shares of Veeva Systems by 59.8% in the 4th quarter. Raiffeisen Bank International AG now owns 155 shares of the technology company’s stock worth $35,000 after acquiring an additional 58 shares during the last quarter. Measured Wealth Private Client Group LLC bought a new position in Veeva Systems in the 3rd quarter valued at about $45,000. Rakuten Securities Inc. lifted its position in Veeva Systems by 56.7% in the 2nd quarter. Rakuten Securities Inc. now owns 163 shares of the technology company’s stock valued at $47,000 after acquiring an additional 59 shares in the last quarter. Finally, Palisade Asset Management LLC acquired a new position in Veeva Systems during the 3rd quarter valued at about $66,000. Institutional investors and hedge funds own 88.20% of the company’s stock.

About Veeva Systems

Veeva Systems (NYSE: VEEV) is a cloud software company that develops industry-specific applications and data solutions for the global life sciences sector. Founded in 2007 and headquartered in Pleasanton, California, Veeva focuses on helping pharmaceutical, biotechnology, medical device and consumer health companies manage regulated content, clinical and regulatory processes, quality systems, and commercial operations in a compliant, cloud-native environment. The company completed its initial public offering in 2013 and has since expanded its product suite and international footprint.

Veeva’s product portfolio centers on its Vault platform and related application suites, which provide content and data management, clinical trial and regulatory workflows, quality management, and structured commercial capabilities such as customer relationship management and promotional content management.